Complete ICD-10-CM coding and documentation guide for Ductal Carcinoma In Situ. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Ductal Carcinoma In Situ
Carcinoma in situ of breast
This range includes all types of carcinoma in situ of the breast, with specific codes for ductal carcinoma in situ.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
D05.1 | Intraductal carcinoma in situ of breast | Use when DCIS is confirmed via biopsy and documented with laterality. |
|
D05.8 | Other specified carcinoma in situ of breast | Use for rare subtypes of DCIS not covered by D05.1. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Ductal Carcinoma In Situ
Use for rare subtypes of DCIS not covered by D05.1.
Ensure subtype is documented in pathology report.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Personal history of breast cancer
Z85.3Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Lobular carcinoma in situ
D05.0Avoid these common documentation and coding issues when documenting Ductal Carcinoma In Situ to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D05.1.
Clinical: Impacts treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Include nuclear grade in all pathology reports.
Reimbursement: May lead to incorrect billing and reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.
Verify laterality in the medical record before coding.
Using unspecified codes when specific information is available.
Ensure all documentation is reviewed for specificity before coding.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Ductal Carcinoma In Situ, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Ductal Carcinoma In Situ. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Ductal Carcinoma In Situ? Ask your questions below.